EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 29-Nov-2025 07:11 ET (29-Nov-2025 12:11 GMT/UTC)

24-Nov-2025

UC Irvine-led study finds global embrace of integrative cancer care

University of California - Irvine
Peer-Reviewed Publication

Around the world, doctors, nurses and pharmacists are turning to evidence-based integrative approaches such as acupuncture, yoga, exercise, massage and nutrition counseling to help people with cancer manage the harsh side effects of treatment.

Journal: BMC Complementary Medicine and Therapies

24-Nov-2025

University of Cincinnati study advances understanding of pancreatic cancer treatment resistance

University of Cincinnati
Peer-Reviewed Publication

A new study published in the journal Cancer Research led by University of Cincinnati Cancer Center researchers sheds new light on how pancreatic cancer cells develop treatment resistance and points to potential new combination therapies to make treatments more effective.

Journal: Cancer Research

24-Nov-2025

LSU LCMC Health Cancer Center researchers uncover key immune differences in triple-negative breast cancer

Louisiana State University Health Sciences Center
Peer-Reviewed Publication

Researchers at the LSU LCMC Health Cancer Center have published groundbreaking findings in NPJ Breast Cancer that sheds new light on triple-negative breast cancer (TNBC), one of the most aggressive forms of breast cancer.

Journal: npj Breast Cancer

24-Nov-2025

Gut microbiome connects obesity to cancer, impacting public health

Impact Journals LLC
Peer-Reviewed Publication

A new review was published in Volume 12 of Oncoscience on November 7, 2025, titled “From obesity to cancer: Gut microbiome mechanisms, biomarkers, and U.S. public health strategies.”

Journal: Oncoscience

24-Nov-2025

NRG Oncology adds new leadership members to Developmental Therapeutics, Patient Centered Outcomes Research, Protocol Operations Management, Head and Neck Cancer, and Translational Science committees

NRG Oncology
Business Announcement

NRG Oncology (NRG), a National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group focused on improving outcomes for adults with cancer through multi-center clinical research, recently announced changes in leadership across multiple committees.

24-Nov-2025

Shapeshifting cancers’ masters, unmasked

Cold Spring Harbor Laboratory
Peer-Reviewed Publication

Research from the Vakoc lab, published in Nature Communications and Cell Reports, provides new insights into the master regulators of two severe forms of lung and pancreatic cancer, which can morph in response to treatment. The discoveries could someday lead to safer therapies with fewer and less harmful side effects.

Journal: Cell Reports
Funder: NIH/National Cancer Institute, Pershing Square Sohn Cancer Research Alliance, Cold Spring Harbor Laboratory, Northwell Health, Treeline Biosciences, NIH/National Institutes of Health, DOD Prostate Cancer Research Program

24-Nov-2025

Particle accelerator waste could help produce cancer-fighting materials, study suggests

University of York
Peer-Reviewed Publication

Energy that would normally go to waste inside powerful particle accelerators could be used to create valuable medical isotopes, scientists have found.

Journal: Physical Review C

24-Nov-2025

Blood protein profiles can predict mortality

University of Surrey
Peer-Reviewed Publication

Elevated levels of five proteins in our blood can help predict risk of mortality, a new study from the University of Surrey finds. Scientists believe the proteins (PLAUR, SERPINA3, CRIM1, DDR1 and LTBP2), that play key roles in the development of diseases such as cancer and inflammation, may also contribute to the risk of dying. Findings could help clinicians identify individuals most at risk from mortality and lead to earlier medical interventions.

Journal: PLOS One

24-Nov-2025

Synthetic stress hormone dexamethasone could reduce breast cancer metastases

University of Basel
Peer-Reviewed Publication

The drug dexamethasone supplements cancer treatments to alleviate side effects of chemotherapy such as nausea or inflammation. Researchers at the University of Basel, Switzerland, have now discovered that it also fights metastases in certain types of breast cancer.

Journal: EMBO Molecular Medicine

24-Nov-2025

Novel liver cancer vaccine achieves responses in rare disease affecting children and young adults

Johns Hopkins Medicine
Peer-Reviewed Publication

An experimental cancer vaccine developed at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy has shown early promise in a phase I clinical trial for a rare form of liver cancer that primarily affects children and young adults.

Journal: Nature Medicine
Funder: NIH/National Institutes of Health, Fibrolamellar Cancer Foundation, ASCO Career Development Award, BSM Rare Cancers, TIRTL Blue Sky Initiative, ALSAC at St. Jude